NVCT
Nuvectis Pharma·NASDAQ
--
--(--)
--
--(--)
NVCT Filings
Filing Date
Form Description
Form Type
2026-02-23
Form EFFECT - Notice of Effectiveness
2026-02-23 ·
Form EFFECT - Notice of Effectiveness
2026-02-18
Form UPLOAD - SEC-generated letter
SEC Inquiries
2026-02-18 · SEC Inquiries
Form UPLOAD - SEC-generated letter
2026-02-18
Form CORRESP - Correspondence
SEC Inquiries
2026-02-18 · SEC Inquiries
Form CORRESP - Correspondence
2026-02-13
Form S-3 - Registration statement under Securities Act of 1933
2026-02-13 ·
Form S-3 - Registration statement under Securities Act of 1933
2026-02-11
Form 8-K - Current report
Key Events
2026-02-11 · Key Events
Form 8-K - Current report
2026-02-11
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-02-11 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-01-09
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-09 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-09
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-09 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-09
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-09 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-09
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-09 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
